The experience of minimally invasive – endoscopic methods used to stop bleeding in upper sections of the digestive system
Introduction. Over the past decade, the number of minimally invasive surgical interventions both in the scheduled and urgent endoscopic surgery has increased significantly. With the development of modern video endoscopic systems, endoscopic surgical tools and accessories have been actively developing. A modern development is Hemosprey from Cook, which is certified and has been widely used in the countries of the European Union, Canada, and the USA since 2011. It is provided in the form of dry hemostatic glue of inorganic origin, which is endoscopically delivered with the help of aerosol. When the powder contacts with blood, it absorbs water and creates a gel that acts as a cohesive and adhesive by creating a stable mechanical barrier around the bleeding site. This methodology is not common in Ukraine, therefore we have made an attempt to study the efficiency of this drug in the regional hospital setting. The relevance of this issue is highlighted by the high morbidity among the population – an average number of people hospitalized with bleeding constitutes 1 per 1000 people. Depending on the etiological factor, the mortality rate is 3-50%. The general mortality rate in case of gastrointestinal bleeding constitutes 3.1% in Kyiv and 8.5% - generally in Ukraine. Among patients, the working-age population prevails.
The aim. To study the efficiency of the method used to stop bleeding using Hemospray in the settings of endoscopic intervention. To research the efficiency of using hemostatic glue both as a mono-method and in combination with other endoscopic methods for endo-hemostasis of gastrointestinal bleeding.
Materials and methods. The observed cohort included 7 patients (5 men, 2 women) aged 28-79 (average age - 52±7.1), who during the first stage received treatment at Lviv Regional clinical hospital, surgery department No. 3, surgery department No. 2, and during the second stage in 2018-2019 – at the gastroenterological department of Lviv Regional Clinical Hospital. Video endoscope Fujinone-250, clipping devices Hemoclips from Olympus, Hemosprey preparation for hemostasis, manufacturer – Cook. When the bleeding stopped, powder hemostasis was combined with clipping of the bleeding source upon the surgeon-endoscopist’s decision.
Results. This endoscopic hemostasis using Hemospray resulted in the avoidance of urgent surgery and saved the lives of 7 patients both when used as a mono-method and when combined with endoscopic clipping with subsequent conservative therapy. None of the patients had recurrent bleeding. Patients had various etiology and causes of gastrointestinal bleeding. 100% of patients that were treated with the endoscopic hemostasis using Hemospray had a positive effect.
Conclusions. Hemospray shows a high efficiency when it comes to stopping urgent bleeding from upper sections of the digestive system with the help of Hemospray both as a mono-method or in combination with other endoscopic methods. [ 1, 10]. Hemospray has the following key benefits over other endoscopic methods: non-thermal – there is no thermal contact with tissues, which makes it impossible for the high risk of complications to appear; non-traumatic – since no pressure is exerted to stop bleeding, the risk of tissue injury is reduced to zero; Contactless – aerosol delivery system presupposes the need for direct mechanical and contact force; safe – disposable cannulas that come as part of the kit – minimize the risk of infectious disease transmission when contacted with blood; Convenience and ease of use – the powder is used on the source of bleeding, therefore it does not require the in face approach and accurate targeting, which is especially important when working in hard-to-reach places [ 2, 4, 6].
Holster L, Van Beusekom H, Kuipers E, Leebeek F, Maat M, Tjwa E. Effects of a hemostatic powder hemospray on coagulation and clot formation. Endoscopy 2015; 47 (07): 638-645 https://doi.org/10.1055/s-0034-1391353
Arena M, Masci E, Eusebi LH, Iabichino G. Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours. Digestive and Liver Disease
Volume 49, Issue 5, May 2017, Pages 514-517 https://doi.org/10.1016/j.dld.2016.12.012
Francesco V, Naegel A, Atreya R, Zopf S, et at. Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding. World J Gastroenterol. 2019 Apr 7; 25(13): 1592–1602. https://doi.org/10.3748/wjg.v25.i13.1592
Hagel A, Albrecht H, Nägel A, Vitali F,Vetter M, Dauth C, Neurath M, and Martin Raithe. The Application of Hemospray in Gastrointestinal Bleeding during Emergency Endoscopy. Gastroenterology Research and Practice.Volume 2017, Article ID 3083481, 8 pages. https://doi.org/10.1155/2017/3083481
Eusebi L, Arena M, Despott E, Masci E, Iabichino G, Mangiavillano B, Viaggi P, Morandi E, Fanti L, Granata A, Traina M. Acute Bleeding Due to Upper Gastrointestinal Tumors Treated With Hemospray: A Case Series From 4 European Endoscopy Centers. GIE.May 2017Volume 85, Issue 5, Supplement, Pages AB457–AB458 DOI: https://doi.org/10.1016/j.gie.2017.03.1065
Curcio G, Barresi L, Ligresti D, Tarantino I, Orlando R, Traina M. Hemospray rescue treatment of severe refractory bleeding associated with ischemic colitis: a case series. International Journal of Colorectal Disease. March 2016, Volume 31, Issue 3, pp 719–720 https://doi.org/10.1007/s00384-015-2212-z
Alzoubaidi D, Magee C, Gulati S, Haji A, Morris J, Lovat L, Hayee B, Haidry R. Outcomes from an international multicentre registry of patients with gastrointestinal bleeding undergoing endoscopic treatment with hemospray. BMJ Journals. Volume 66, Issue Suppl 2
Kosasih S, Jalihal A, Chong VH. Maximizing the use of Hemospray. Indian Journal of Gastroenterology. September 2018, Volume 37, Issue 5, pp 467–468 https://doi.org/10.1007/s12664-018-0913-2
Xavier S, Magalhães J, Rosa B, Cotter J. Hemospray use in upper gastrointestinal bleeding from tumor: Is it the answer? Endosc Int Open 2016; 04(12): E1331-E1332 https://doi.org/10.1055/s-0042-121800
Pittayanon R, Prueksapanich P, Rerknimitr R. The efficacy of Hemospray in patients with upper gastrointestinal bleeding from tumor. Endosc Int Open 2016; 04(09): E933-E936// https://doi.org/10.1055/s-0042-109863
Gubler C, Turina M. Hemospray treatment for bleeding intestinal anastomoses in the early postoperative period: a novel non-operative approach. Techniques in Coloproctology. July 2016, Volume 20, Issue 7, pp 495–498 https://doi.org/10.1007/s10151-016-1484-9
Vitali F, Näge A, Siebler J, Neurath MF, Rath T. Efficacy of hemospray and and endoclot in the treatment of gastrointestinal bleeding: results from a tertiary referral center. Endoscopy 2018; 50(04): S7// https://doi.org/10.1055/s-0038-1637044
Santiago R, Santamaría B, Carazo P, Lantaron T, Brullet E, Leira P, Pons R, Sainz F.
Hemospray for gastrointestinal bleeding: effectiveness, predictors of failure and survival in a nationwide study. Endoscopy 2019; 51(04): S62// https://doi.org/10.1055/s-0039-1681353
Cahyadi O, Bauder M, Meier B, Caca K, Schmidt A. Effectiveness of TC-325 (Hemospray) for treatment of diffuse or refractory upper gastrointestinal bleeding – a single center experience. Endosc Int Open 2017; 05(11): E1159-E1164// https://doi.org/10.1055/s-0043-118794
Nasr I, Martino S, Borrow DM, Campling H, Koumoutsos I, Chia C, Dunn J. Hemospray: When Should We Plug the Gap? A Single Centre UK Experience. GIE. May 2016Volume 83, Issue 5, Supplement, Pages AB500–AB501// DOI: https://doi.org/10.1016/j.gie.2016.03.720
Cockerel C, Parsa N, Matteson-Kome M, Samiullah S, Nguyen D, Puli S, Bechtold M.
Hemospray monotherapy for non- varieceal upper GI bleeding: a meta-analysis. June 2019Volume 89, Issue 6, Supplement, Page AB558// DOI: https://doi.org/10.1016/j.gie.2019.03.951
Kwek A, Ang T, Ong PL, Tan YL, Ang D, Law N, Thurairajah P, Fock K. Hemospray Versus the Combined Conventional Technique for Endoscopic Treatment of Bleeding Peptic Ulcers: A Pilot Randomized Controlled Study. GIE. May 2016Volume 83, Issue 5, Supplement, Pages AB123–AB124// DOI: https://doi.org/10.1016/j.gie.2016.03.040
Uday A, Jothimani S, Rela M. Hemospray for Recurrent Oesophageal Band Ulcer Bleeding. Journal of Clinical and Experimental Hepatology. July 2017Volume 7, Supplement 2, Page S95 https://doi.org/10.1016/j.jceh.2017.05.171
Appleby R, Hoare J. Hemospray in a large tertiary nhs trust: a descriptive analysis of the first three years of use. . Gut, suppl.2 ; London Vol. 66, (Jul 2017): A216. https://doi.org/10.1136/gutjnl-2017-314472.419
Ivekovic H, Bilic B,Markos P, Rustemovic N, Ostojic R, Mönkemüller K. Successful use of Hemospray to control refractory post-polypectomy bleeding. Endoscopy 2015; 47(S 01): E466-E467// https://doi.org/10.1055/s-0034-1392865
Venezia G, Asnaghi G, Manca A, Ghezzo L. Successful use of Hemospray as a bridge to surgery in life-threatening bleeding from a gastrointestinal stromal tumor of the stomach. Endoscopy 2016; 48(S 01): E232-E233// https://doi.org/10.1055/s-0042-109600
Smith, L. A., Stanley, A. J., Bergman, J. J., Kiesslich, R., Hoffman, A., Tjwa, E. T., ... & Schmidt, P. N. Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the Survey to Evaluate the Application of Hemospray in the Luminal Tract. Journal of clinical gastroenterology 2014, 48(10), e89-e92. https://doi.org/10.1097/MCG.0000000000000054
Abstract views: 170 PDF Downloads: 139 PDF Downloads: 0
This work is licensed under a Creative Commons Attribution 4.0 International License.